BR0311518A - Monoterapia para o tratamento de esclerose lateral amiotrófica com inibidor(es) de ciclooxigenase-2 (cox 2) - Google Patents

Monoterapia para o tratamento de esclerose lateral amiotrófica com inibidor(es) de ciclooxigenase-2 (cox 2)

Info

Publication number
BR0311518A
BR0311518A BR0311518-6A BR0311518A BR0311518A BR 0311518 A BR0311518 A BR 0311518A BR 0311518 A BR0311518 A BR 0311518A BR 0311518 A BR0311518 A BR 0311518A
Authority
BR
Brazil
Prior art keywords
inhibitor
treatment
cox
monotherapy
cyclooxygenase
Prior art date
Application number
BR0311518-6A
Other languages
English (en)
Inventor
Peter C Isakson
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of BR0311518A publication Critical patent/BR0311518A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MONOTERAPIA PARA O TRATAMENTO DE ESCLEROSE LATERAL AMIOTRóFICA COM INIBIDOR(ES) DE CICLOOXIGENASE-2 (COX 2)". A presente invenção refere-se a um método para tratar, prevenir ou inibir ALS, em um indivíduo em necessidade de tal tratamento, inibição ou prevenção. O método compreende administrar a um indivíduo um ou mais isómero(s) ou inibidor(es) seletivo(s) de ciclooxigenase-2 ou sal(is) farmaceuticamente aceitável(is), ester(es) ou pró-medicamento(s) destes, onde a quantidade do(s) inibidor(es) seletivos de ciclooxigenase-2, isómero(s), ester(es), sal(is) ou pró-medicamento(s) destes constituem um tratamento de ALS, inibição ou prevenção com quantidade eficaz do(s) inibidor(es) de COX 2.
BR0311518-6A 2002-05-31 2003-05-28 Monoterapia para o tratamento de esclerose lateral amiotrófica com inibidor(es) de ciclooxigenase-2 (cox 2) BR0311518A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38413902P 2002-05-31 2002-05-31
US10/444,072 US20040063752A1 (en) 2002-05-31 2003-05-23 Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (COX-2) inhibitor(s)
PCT/US2003/014548 WO2003101441A1 (en) 2002-05-31 2003-05-28 Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (cox 2) inhibitor(s)

Publications (1)

Publication Number Publication Date
BR0311518A true BR0311518A (pt) 2005-02-22

Family

ID=29715311

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0311518-6A BR0311518A (pt) 2002-05-31 2003-05-28 Monoterapia para o tratamento de esclerose lateral amiotrófica com inibidor(es) de ciclooxigenase-2 (cox 2)

Country Status (10)

Country Link
US (1) US20040063752A1 (pt)
EP (1) EP1509217A1 (pt)
JP (1) JP2005531592A (pt)
CN (1) CN1658853A (pt)
AU (1) AU2003232096A1 (pt)
BR (1) BR0311518A (pt)
CA (1) CA2487923A1 (pt)
MX (1) MXPA04011955A (pt)
PL (1) PL373800A1 (pt)
WO (1) WO2003101441A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2505514A1 (en) * 2002-11-06 2004-05-27 Mount Sinai School Of Medicine Treatment of amyotrophic lateral sclerosis with nimesulide
US20070281927A1 (en) * 2006-06-06 2007-12-06 Shanthakumar Tyavanagimatt Anti-inflammatory and analgesic compositions and related methods
CN110357824A (zh) * 2019-06-10 2019-10-22 中山大学 [3,5-二取代苯基-1-(1,2,4-三氮唑基)]苯磺酸衍生物及制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985930A (en) * 1996-11-21 1999-11-16 Pasinetti; Giulio M. Treatment of neurodegenerative conditions with nimesulide

Also Published As

Publication number Publication date
PL373800A1 (en) 2005-09-19
CN1658853A (zh) 2005-08-24
JP2005531592A (ja) 2005-10-20
AU2003232096A1 (en) 2003-12-19
US20040063752A1 (en) 2004-04-01
CA2487923A1 (en) 2003-12-11
EP1509217A1 (en) 2005-03-02
MXPA04011955A (es) 2005-03-31
WO2003101441A1 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
BR0317183A (pt) Método de usar compostos de aminocianopiridina como inibidores de proteìna quinase-2 ativada por proteìna quinase ativada por mitógeno
BR0304648A (pt) Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia
BR0309259A (pt) Terapia combinada para o tratamento de doença de parkinson com inibidores de ciclooxigenase-2 (cox 2)
BRPI0408784A (pt) método para usar um composto
DE69939651D1 (de) Behandlung hyperproliferativer erkrankungen
PL1983000T3 (pl) Sposób leczenia stwardnienia rozsianego przez hamowanie aktywności IL-17
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
PL373903A1 (en) A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
BRPI0618371A2 (pt) combinação de compostos orgánicos
PT752813E (pt) Inibidores de proteases de parasitas metazoarios
DK0840606T3 (da) Små di- og trivalente molekyler som selectininhibitorer
WO2003092606A3 (en) Cholinesterase inhibitors to prevent injuries caused by chemicals
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
BR0317361A (pt) Método de tratamento, prevenção ou inibição de um distúrbio do snc e/ou dor e inflamação utilizando uma associação de duloxetina, venlafaxina ou atomoxetina e um inibidor seletivo da ciclooxigenase-2 e suas formulações
BR0113389A (pt) Compostos que inibem a atividade do fator xa
WO2002039994A3 (en) Methods for the treatment and prevention of urinary stone disease
BR9909872A (pt) uso de dexmedetomidina para uma unidade de sedação de proteção intensiva
PT838223E (pt) Inibidor do edema cerebral
BRPI0414822A (pt) método de inibir a produção de lipoproteìna remanescente
BR0311524A (pt) Terapia de combinação para o tratamento de esclerose lateral amiotrófica (als) com inibidor(es) de ciclooxigenase-2 (cox 2) e uma segunda droga
HUP9801022A2 (hu) Eljárás aldóz reduktáz inhibítor alkalmazása diabetikus szívizom-betegség megelőzésére vagy megfordítására
BR0311518A (pt) Monoterapia para o tratamento de esclerose lateral amiotrófica com inibidor(es) de ciclooxigenase-2 (cox 2)
BR0212989A (pt) Métodos para tratamento neuroprotetor usando inibidores de inos seletivos
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
UY30557A1 (es) Tratamiento y prevencion de la fibrosis intestinal

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A E 7A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2064 DE 27/07/2010.